GJB2 p.V37I 突变与成年台湾人群中度非综合征性听力损失相关
研究从台湾精准医学计划13580名参与者中选取病例对照样本,分析GJB2 p.V37I纯合/复合杂合38人、杂合129人及野生型602人的听力学特征。该突变的次要等位基因频率为0.92%,与听力残疾风险升高相关(比值比21.46,95%CI 8.62–53.44,p<0.001),呈常染色体隐性模式。作者建议已知携带该突变的患者定期接受听力学评估和遗传咨询,并建议早期助听设备干预。
要点
- GJB2 p.V37I次要等位基因频率为0.92%,是成年台湾人群感音神经性听力损失的重要致病变异。
- p.V37I突变者平均听力水平提示中度至重度听力损失,双耳听力受损比例为38.2%±22.3%。
- GJB2 p.V37I与听力残疾风险升高相关(比值比21.46,95%CI 8.62–53.44,p<0.001)。
核心结论
- GJB2 p.V37I是成年台湾人群中致病且常见的感音神经性听力损失变异。
- 作者建议已知携带GJB2 p.V37I突变的患者定期接受听力学评估和遗传咨询。
- 作者建议早期助听设备干预以改善听力质量。
研究设计与样本
- 病例对照研究,受试者选自台湾精准医学计划的13580名参与者。
- 通过聚合酶链反应测定GJB2 p.V37I遗传变异。
- 分析38名GJB2 p.V37I纯合或复合杂合子、129名杂合子及602名野生型的现有纯音听阈数据。
- 进行全表型组关联研究(PheWAS)以识别与GJB2 p.V37I相关的表型。
主要发现
- 研究人群中GJB2 p.V37I的次要等位基因频率为0.92%。
- 携带p.V37I突变者的平均听力水平提示中度至重度听力损失,双耳听力受损比例为38.2%±22.3%。
- GJB2 p.V37I以常染色体隐性模式与听力残疾风险升高相关(比值比21.46,95%CI 8.62–53.44,p<0.001)。
- PheWAS发现GJB2 p.V37I与肱骨骨折存在显著关联。
关键数值与推荐
- GJB2 p.V37I与听力残疾的比值比为21.46(95%CI 8.62–53.44,p<0.001)。
- GJB2 p.V37I的次要等位基因频率为0.92%。
- 双耳听力受损比例为38.2%±22.3%。
临床怎么用
- 作者建议已知GJB2 p.V37I突变的患者定期接受听力学评估和遗传咨询。
- 作者建议早期助听设备干预以改善听力质量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gap junction protein beta 2 ( GJB2 ) p.V37I mutations are the most important hereditary cause of sensorineural hearing loss (SNHL) in Taiwan. Hearing outcomes are associated with hearing levels at baseline and the duration of follow-up. However, the audiological features of GJB2 p.V37I mutations in the adult population are unknown. The objectives of the present study were to investigate the audiological features, progression rate, and allele frequency of GJB2 p.V37I mutations among an adult Taiwanese population. METHODS: Subjects of this case-control study were chosen from 13,580 participants of the Taiwan Precision Medicine Initiative. The genetic variations of GJB2 p.V37I were determined by polymerase chain reaction. We analyzed existing pure-tone threshold data from 38 individuals who were homozygous or compound heterozygotes for GJB2 p.V37I, 129 who were heterozygotes, and 602 individuals who were wild-type. Phenome-wide association studies (PheWAS) analysis was also performed to identify phenotypes associated with GJB2 p.V37I. RESULTS: The minor allele frequency of GJB2 p.V37I was 0.92% in our study population. The mean hearing level of participants with a p.V37I mutation indicated moderate to severe hearing loss with 38.2% ± 22.3% binaural hearing impairment. GJB2 p.V37I was associated with an increased risk of hearing disability (odds ratio: 21.46, 95% confidence interval: 8.62 to 53.44, p < 0.001) in an autosomal recessive pattern. In addition, PheWAS discovered a significant association between GJB2 p.V37I and fracture of the humerus. GJB2 p.V37I is a pathogenic and prevalent variant of SNHL among the adult population. CONCLUSIONS: The present study recommends patients with known GJB2 p.V37I mutations receive regular audiometric evaluation and genetic counseling. Early assistive listening device intervention is suggested to improve the quality of hearing.
引用
- Yen TT, Chen IC, Cho S, et al. GJB2 p.V37I Mutation Associated With Moderate Nonsyndromic Hearing Loss in an Adult Taiwanese Population. Ear Hear. 2023. PMID: 37271870. doi:10.1097/AUD.0000000000001384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。